Trinity Life Sciences Acquires CBPartners
Summary
The acquisition significantly scales Trinity’s Value, Access and Pricing business, adding over 75 dedicated experts to the Company. “We are excited to offer the additional services in the Trinity portfolio – commercial strategy, launch planning, market research, forecasting, benchmarking, etc. With the addition of CBPartners, Trinity is better poised to help our clients revolutionize the commercial model and provide their drugs to patients around the world. The aligned cultures and values of both companies reflect an evidence-first approach to helping clients make critical business decisions. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools and data-driven insights.